Locations:
Search
First report of major endpoint reduction in patients with biopsy-proven NASH
Leader plans to collaborate with other medical disciplines for the benefits of patients with obesity.
New study finds that the average patient can expect to lose an additional 3.5kg on canagliflozin
Weight fluctuations after year one less important than percentage of weight loss in year one, study suggests
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement